Carlyle to take stake in Salubris
The Carlyle Group has agreed to acquire a 5 percent stake in Salubris, a China-based biopharmaceutical company.
2 September 2020•4 mins read
The Carlyle Group has agreed to acquire a 5 percent stake in Salubris, a China-based biopharmaceutical company.
Levine Leichtman makes growth investment in utility adviser Concentric Energy Advisors
2 minutes ago · 2 mins read
One Rock strikes $650m deal for Kraft Heinz’s North America coffee business
10 minutes ago · 2 mins read
LLCP bullish on loan services following GLAS sale to Oakley Capital
2 hours ago · 2 mins read
Butterfly Equity sees food packaging as essential after debuting in sector
3 hours ago · 3 mins read
Heartwood Partners’ NativeSeed Group acquires assets of Kansas seed cleaner Sharp Brothers
3 hours ago · 1 min read
Arcline’s Signia Aerospace to acquire JLL Partners’ Heads Up Technologies
4 hours ago · 1 min read
Ansor’s Corvero acquires Northern Ireland aerospace tooling specialist Datum Design
4 hours ago · 2 mins read
